[#JPM2025 #Interview] Check out the latest interview!🎙️

Mediwhale is making significant strides in global expansion with its AI-powered retina-based cardiovascular disease prediction software, Dr. Noon CVD. 

At the 43rd J.P. Morgan Healthcare Conference (JPM 2025) in San Francisco, CEO Kevin Choi and COO Nina Nahyeon Shin highlighted the company's successful entry into the Middle East market through a partnership with Dubai-based diabetes clinic Glucare.

With plans to expand further into the U.S., Europe, and Southeast Asia, Mediwhale aims to address the growing demand for preventive healthcare solutions. 

The company expects to secure FDA approval by the end of this year or early next year, paving the way for strategic partnerships in the U.S. market. 

Read more about Mediwhale's journey and future plans in the Korea Biomedical Review.
#JPM2025 #Interview